Form 4 for CATX Perspective Therapeutics, Inc.

Accepted 2025-04-01 00:00:00 ET · period of report 2025-03-28 · accession 0000950170-25-048775 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2025-04-01	2025-03-28	CATX	Spoor Johan M.	CEO, Dir	P - Purchase	$2.21	+4,650	4,650	New	+$10.3K
	2025-04-01	2025-03-28	CATX	Spoor Johan M.	CEO, Dir	P - Purchase	$2.24	+22.0K	59.4K	+59%	+$49.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-03-28	P	A	4,650	$2.21	4,650	I	—	—	(F3) The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1900 to $2.2450, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.
2	Common	Common Stock	2025-03-28	P	A	22,026	$2.24	59,383	D By Child #1	—	—	(F1) The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1900 to $2.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote. (F2) Previous Form 4s filed on behalf of the Reporting Person under-reported the Reporting Person's holdings by 1,100 shares of Common Stock. The amount reported in this Form 4 reflects the correct amount.